Vedolizumab, a monoclonal antibody to the gut homing α4β7 integrin, does not affect cerebrospinal fluid T-lymphocyte immunophenotypeCatherine Milch, Joseph R. Berger, Tim Wyant et al.|Journal of Neuroimmunology|2013Cited by 77
Vedolizumab does not reduce the CD4+:CD8+ ratio in the CSF of healthy volunteersCatherine Milch, Irving H. Fox, Joseph R. Berger et al.|Inflammatory Bowel Diseases|2011Cited by 11
Neurogenic differentiation factor NeuroD confers protection against radiation-induced intestinal injury in miceMing Li, Jianping Cao, Xiao-Dong Yang et al.|Scientific Reports|2016Cited by 11